-
2
-
-
0003112857
-
Extracorporeal perfusion
-
LH Edmunds Jr, editor. New York: McGraw-Hill
-
Edmunds LH Jr. Extracorporeal perfusion. In: LH Edmunds Jr, editor. Cardiac surgery in the adult. New York: McGraw-Hill, 1996.
-
(1996)
Cardiac Surgery in the Adult
-
-
Edmunds Jr., L.H.1
-
3
-
-
0023273753
-
Neurologic and neuropsychological morbidity following major surgery: Comparison of coronary artery bypass and peripheral vascular surgery
-
Shaw PJ, Bates D, Aartidge NEF, et al. Neurologic and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery. Stroke 1987;18:700-7.
-
(1987)
Stroke
, vol.18
, pp. 700-707
-
-
Shaw, P.J.1
Bates, D.2
Aartidge, N.E.F.3
-
4
-
-
0028838024
-
Microemboli during coronary artery bypass grafting: Genesis and effect on outcome
-
Clark RE, Brillman J, Davis DA, Lovell MR, Price TR, Magovern GJ. Microemboli during coronary artery bypass grafting: genesis and effect on outcome. J Thorac Cardiovasc Surg 1995;109:249-58.
-
(1995)
J Thorac Cardiovasc Surg
, vol.109
, pp. 249-258
-
-
Clark, R.E.1
Brillman, J.2
Davis, D.A.3
Lovell, M.R.4
Price, T.R.5
Magovern, G.J.6
-
5
-
-
0002320751
-
Embolic events and cardiopulmonary bypass
-
Gravlee GP, Davis RE, Utley JR, editors. Baltimore: Williams and Wilkins
-
Kurusz M, Butler BD. Embolic events and cardiopulmonary bypass. In: Gravlee GP, Davis RE, Utley JR, editors. Cardiopulmonary bypass. Baltimore: Williams and Wilkins, 1993:267-90.
-
(1993)
Cardiopulmonary Bypass
, pp. 267-290
-
-
Kurusz, M.1
Butler, B.D.2
-
6
-
-
0026739971
-
Release of vasoactive substances during cardiopulmonary bypass
-
Downing SW, Edmunds LH Jr. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 1992;54:1236-43.
-
(1992)
Ann Thorac Surg
, vol.54
, pp. 1236-1243
-
-
Downing, S.W.1
Edmunds Jr., L.H.2
-
7
-
-
0018899725
-
Elevated plasma fibrinopeptide-A and thromboxane-B2 levels during cardiopulmonary bypass
-
Davies GC, Sobel M, Salzman EW. Elevated plasma fibrinopeptide-A and thromboxane-B2 levels during cardiopulmonary bypass. Circulation 1980;61:808-14.
-
(1980)
Circulation
, vol.61
, pp. 808-814
-
-
Davies, G.C.1
Sobel, M.2
Salzman, E.W.3
-
8
-
-
0027249775
-
Thrombin generation during cardiac surgery: Is heparin the ideal anticoagulant?
-
Brister SJ, Ofosu FA, Buchanan MR. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant? Thromb Haemost 1993;70:259-62.
-
(1993)
Thromb Haemost
, vol.70
, pp. 259-262
-
-
Brister, S.J.1
Ofosu, F.A.2
Buchanan, M.R.3
-
9
-
-
0023622165
-
Baboon models of acute arterial thrombosis
-
Hanson SR, Harker LA. Baboon models of acute arterial thrombosis. Thromb Haemost 1987;58:801.
-
(1987)
Thromb Haemost
, vol.58
, pp. 801
-
-
Hanson, S.R.1
Harker, L.A.2
-
10
-
-
0018649114
-
Antiheparin proteins secreted by human platelets: Purification, characterization and radioimmunoassay
-
Rucinski B, Niewiarowski S, James P, Walz DA, Budzynski Z. Antiheparin proteins secreted by human platelets: purification, characterization and radioimmunoassay. Blood 1979; 53:47-62.
-
(1979)
Blood
, vol.53
, pp. 47-62
-
-
Rucinski, B.1
Niewiarowski, S.2
James, P.3
Walz, D.A.4
Budzynski, Z.5
-
13
-
-
0026071629
-
Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against synthetic peptide
-
Pelzer H, Schwartz A, Stuber W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against synthetic peptide. Thromb Haemost 1991;65: 153.
-
(1991)
Thromb Haemost
, vol.65
, pp. 153
-
-
Pelzer, H.1
Schwartz, A.2
Stuber, W.3
-
14
-
-
0021690019
-
Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A
-
Amiral J, Walenga JM, Fareed J. Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A. Semin Thromb Hemost 1984;10:228.
-
(1984)
Semin Thromb Hemost
, vol.10
, pp. 228
-
-
Amiral, J.1
Walenga, J.M.2
Fareed, J.3
-
15
-
-
12644302622
-
Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay
-
Pelzer H, Schwarz A, Heimberger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1993;50:740-4.
-
(1993)
Thromb Haemost
, vol.50
, pp. 740-744
-
-
Pelzer, H.1
Schwarz, A.2
Heimberger, N.3
-
16
-
-
0021084637
-
An immunoassay for human D-dimer using monoclonal antibodies
-
Rylatt DB, Blake AS, Cottlis LE, et al. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 1983;31:767-78.
-
(1983)
Thromb Res
, vol.31
, pp. 767-778
-
-
Rylatt, D.B.1
Blake, A.S.2
Cottlis, L.E.3
-
17
-
-
0027532975
-
Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli
-
de Boer JP, Creasy AA, Chang A, et al. Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli. Circ Shock 1993;39:59-67.
-
(1993)
Circ Shock
, vol.39
, pp. 59-67
-
-
De Boer, J.P.1
Creasy, A.A.2
Chang, A.3
-
18
-
-
0023795421
-
Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3: An analysis with monoclonal antibodies
-
Hack CE, Paardekooper J, Smeenk RJT, Abbink JJ, Eerenberg AJM, Nuijens JH. Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3: an analysis with monoclonal antibodies. J Immunol 1988;141:1602-9.
-
(1988)
J Immunol
, vol.141
, pp. 1602-1609
-
-
Hack, C.E.1
Paardekooper, J.2
Smeenk, R.J.T.3
Abbink, J.J.4
Eerenberg, A.J.M.5
Nuijens, J.H.6
-
19
-
-
0025291095
-
Demonstration in human plasma of a form of C3 that has the conformation of "C3b-like C3"
-
Hack CE, Paardekooper J, van Milligen F. Demonstration in human plasma of a form of C3 that has the conformation of "C3b-like C3". J Immunol 1990;144:4249-55.
-
(1990)
J Immunol
, vol.144
, pp. 4249-4255
-
-
Hack, C.E.1
Paardekooper, J.2
Van Milligen, F.3
-
20
-
-
0027451566
-
Activation of the complement system in baboons challenged with live escherichia coli: Correlation with mortality and evidence for a biphasic activation pattern
-
de Boer JP, Creasey AA, Chang A, et al. Activation of the complement system in baboons challenged with live escherichia coli: correlation with mortality and evidence for a biphasic activation pattern. Infect Immun 1993;61:4293-301.
-
(1993)
Infect Immun
, vol.61
, pp. 4293-4301
-
-
Boer, J.P.1
Creasey, A.A.2
Chang, A.3
-
21
-
-
0027179963
-
Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway
-
Wolbink GJ, Bollen M, Baars JW, et al. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway. J Immunol Methods 1993;163:67-76.
-
(1993)
J Immunol Methods
, vol.163
, pp. 67-76
-
-
Wolbink, G.J.1
Bollen, M.2
Baars, J.W.3
-
22
-
-
0026579119
-
1 antitrypsin and lactoferrin in sepsis: Evidence for neutrophils as mediators in fatal sepsis
-
1 antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med 1992;119:159-67.
-
(1992)
J Lab Clin Med
, vol.119
, pp. 159-167
-
-
Nuijens, J.H.1
Abbink, J.J.2
Wachtfogel, Y.T.3
-
23
-
-
0030004172
-
Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass
-
Chung JH, Gikakis N, Drake TA, Colman RW, Edmunds LH Jr. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 1996;93:2014-8.
-
(1996)
Circulation
, vol.93
, pp. 2014-2018
-
-
Chung, J.H.1
Gikakis, N.2
Drake, T.A.3
Colman, R.W.4
Edmunds Jr., L.H.5
-
24
-
-
0011773918
-
Cardiac dysfunction caused by purified human C3a anaphylatoxin
-
Del Balza UH, Levi R, Polley MJ. Cardiac dysfunction caused by purified human C3a anaphylatoxin. Proc Nat Acad Sci USA 1985;82:886-90.
-
(1985)
Proc Nat Acad Sci USA
, vol.82
, pp. 886-890
-
-
Del Balza, U.H.1
Levi, R.2
Polley, M.J.3
-
25
-
-
0026323622
-
Ovine platelet factor 4: Purification, amino acid sequence, radioimmunoassay and comparison with platelet factor 4 of other species
-
Shigeta O, Lu W, Holt JC, Edmunds LH Jr, Niewiarowski S. Ovine platelet factor 4: purification, amino acid sequence, radioimmunoassay and comparison with platelet factor 4 of other species. Thromb Res 1991;64:509-20.
-
(1991)
Thromb Res
, vol.64
, pp. 509-520
-
-
Shigeta, O.1
Lu, W.2
Holt, J.C.3
Edmunds Jr., L.H.4
Niewiarowski, S.5
-
26
-
-
0018193474
-
Function of monkey (M Mulatta) platelets compared to platelets of pig, sheep and man
-
Addonizio VP Jr, Edmunds LH Jr, Colman RW. Function of monkey (M Mulatta) platelets compared to platelets of pig, sheep and man. J Lab Clin Med 1978;91:989-97.
-
(1978)
J Lab Clin Med
, vol.91
, pp. 989-997
-
-
Addonizio Jr., V.P.1
Edmunds Jr., L.H.2
Colman, R.W.3
-
27
-
-
0019293923
-
Solid-phase immunoassay of dog neutrophil elastase
-
Kucich V, Abrams WR, James HL. Solid-phase immunoassay of dog neutrophil elastase. Anal Biochem 1980;109:403-9.
-
(1980)
Anal Biochem
, vol.109
, pp. 403-409
-
-
Kucich, V.1
Abrams, W.R.2
James, H.L.3
-
28
-
-
0023656087
-
Isolation and characterization of an inhibitor from bovine plasma
-
Thornton RD, Kirby EP. Isolation and characterization of an inhibitor from bovine plasma. J Biol Chem 1987;262:12714-21.
-
(1987)
J Biol Chem
, vol.262
, pp. 12714-12721
-
-
Thornton, R.D.1
Kirby, E.P.2
-
29
-
-
0025269171
-
Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig
-
Nilsson L, Storm KE, Thelin S, Bagge L, Hultman J, Thorelius J, et al. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. Artif Organs 1989;14:46-8.
-
(1989)
Artif Organs
, vol.14
, pp. 46-48
-
-
Nilsson, L.1
Storm, K.E.2
Thelin, S.3
Bagge, L.4
Hultman, J.5
Thorelius, J.6
-
30
-
-
0028901687
-
Reversal of heparin anticoagulation by recombinant platelet factor 4 and protamine sulfate in baboons during cardiopulmonary bypass
-
Bernabei A, Gikakis N, Maione TE, et al. Reversal of heparin anticoagulation by recombinant platelet factor 4 and protamine sulfate in baboons during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1995;109:765-71.
-
(1995)
J Thorac Cardiovasc Surg
, vol.109
, pp. 765-771
-
-
Bernabei, A.1
Gikakis, N.2
Maione, T.E.3
-
31
-
-
0025230919
-
Enhanced effective fibrinolysis following the neutralization of herparin in open heart surgery increases the risk of post-surgical bleeding
-
Gram J, Janetzko T, Jespersen J, Bruhn HD. Enhanced effective fibrinolysis following the neutralization of herparin in open heart surgery increases the risk of post-surgical bleeding. Thromb Haemost 1990;63:248.
-
(1990)
Thromb Haemost
, vol.63
, pp. 248
-
-
Gram, J.1
Janetzko, T.2
Jespersen, J.3
Bruhn, H.D.4
-
33
-
-
18144439851
-
Tirofiban provides "platelet anesthesia" during cardiopulmonary bypass in baboons
-
Hiramatsu Y, Gikakis N, Anderson HL III, Gorman JH III, Marcinkiewicz C, Gould RJ. Tirofiban provides "platelet anesthesia" during cardiopulmonary bypass in baboons. J Thorac Cardiovasc Surg 1997;113:182-93.
-
(1997)
J Thorac Cardiovasc Surg
, vol.113
, pp. 182-193
-
-
Hiramatsu, Y.1
Gikakis, N.2
Anderson III, H.L.3
Gorman III, J.H.4
Marcinkiewicz, C.5
Gould, R.J.6
|